Seven countries take center stage as new survey results reveal which national health systems are fast-tracking - or falling behind - in digital health transformation. NEW YORK CITY, NEW YORK / ACCESS ...

Experienced Medtech Executive to Lead EDGe Surgical Through Commercial Scale-Up and Product Line Expansion CHICAGO, ILLINOIS / ACCESS Newswire / May 12, 2025 / EDGe Surgical, a medical device company ...

POTOMAC, MD / ACCESS Newswire / May 12, 2025 / IGC Pharma, Inc. (NYSE American:IGC) ("IGC" or the "Company") today announced that it presented its latest scientific poster, titled "Genetic Toxicity ...

Genomate Health, a leading precision oncology company, today announced its formal entry into the U.S. market during the SelectUSA Investment Summit, the premier event for international companies ...

BEIJING, CHINA / ACCESS Newswire / May 12, 2025 / CASI Pharmaceuticals, Inc. (Nasdaq:CASI), ("CASI" or the "Company"), a Cayman incorporated biopharmaceutical company focused on developing and ...

MUNICH, DE / ACCESS Newswire / May 12, 2025 / Secarna Pharmaceuticals GmbH & Co. KG, a company redefining the discovery and development of best-in-class oligonucleotide therapeutics, today announced ...

Q1 revenues increased 412% year over year, driven by AI Nose productsDelivers strong turnaround from gross loss to gross profit in Q1AI Nose gains traction beyond healthcare with strategic ...

Advanced Preparation for New Drug Application ~ SAN DIEGO, CA / ACCESS Newswire / May 12, 2025 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a clinical-stage pharmaceutical ...

Vikas Goyal, MBA, promoted to Partner to lead growth stage investments in late preclinical and clinical stage biotechnology companies. BOSTON, MASSACHUSETTS / ACCESS Newswire / May 12, 2025 / Longwood ...

LUXEMBOURG, LU / ACCESS Newswire / May 12, 2025 / Moolec Science SA (NASDAQ:MLEC; the "Company" or "Moolec"), a science-based food ingredient company focused on producing animal proteins and ...

Immuno-oncology pioneer partners with AbTherx to build the next generation of immunotherapy drugs MOUNTAIN VIEW, CA / ACCESS Newswire / May 12, 2025 / AbTherx, Inc., a biotechnology company with ...

Funding will enable company to expand research capacity and scale up unique genome editing technology designed to treat complex, rare diseases while also opening new avenues for protein bioproduction ...